Federal Supply Schedule 36F79723D026E
Award Date
5/18/23
Last Date to Order
9/15/23
Federal Agency
Veterans Integrated Service Network 12
Awardee
Legacy Pharma Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian U.S. federal agency, to Spectrum Pharmaceuticals, Inc., a for-profit manufacturer. The contract, with a ceiling value of $25,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract period of performance extends from the award date of December 16, 2022 to the ultimate completion...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to H2-Pharma LLC, a for-profit limited liability company. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The contract is for 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. This indicates the contract is focused on...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. government, to Genericus, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple award contract with a ceiling value of $850,000.00 and a period of performance ending on December 14, 2029. As a Federal Supply Schedule contract, it allows for the procurement of the specified products and...